Versant Capital Management’s Utah Medical Products UTMD Stock Holding History

Versant Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$34.4K	Buy	464 +24	+5%	+$1.71K	﹤0.01%	1665
2026 Q2	$30.4K	Sell	440 -6	-1%	-$399	﹤0.01%	1711
2026 Q1	$27.6K	Buy	446 +6	+1%	+$378	﹤0.01%	1635
2025 Q4	$24.6K	Sell	440 -77	-15%	-$4.46K	﹤0.01%	1508
2025 Q3	$32.6K	Buy	517 +77	+18%	+$4.56K	﹤0.01%	1286
2025 Q2	$25K	Buy	+440	New	+$23.9K	﹤0.01%	1390
2025 Q1	–	Sell	-198	Closed	-$12.2K	–	2628
2024 Q4	$12.2K	Buy	+198	New	+$12.8K	﹤0.01%	1300

Other funds holding UTMD

Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $861M AUM 27.19% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Versant Capital Management's UTMD Position: Q3 2026 in Review

Versant Capital Management increased its Utah Medical Products (UTMD) stake by 5.5% in Q3 2026, buying an estimated $1.71K and bringing the position to 464 shares worth $34.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1665.

Versant Capital Management first reported a position in UTMD in Q4 2024 and has held it in 7 quarters since. 17 funds tracked by Wall St. Rank hold UTMD as of Q3 2026.

Versant Capital Management held 464 shares of Utah Medical Products worth $34.4K as of Q3 2026.
Versant Capital Management bought 24 Utah Medical Products shares in Q3 2026, an estimated $1.71K.
Utah Medical Products made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1665 holding.
Versant Capital Management first reported a position in Utah Medical Products in Q4 2024 and has held it in 7 quarters since.
17 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.